The Pitanium Limited (PTNM) SEC filings page provides access to the company’s regulatory reports as a foreign private issuer listed on the Nasdaq Capital Market. Pitanium is incorporated in the British Virgin Islands and operates as a retailer in Hong Kong, focusing on proprietary beauty and personal care brands such as PITANIUM and BIG PI sold online and through six local retail stores.
As a foreign private issuer, Pitanium files an annual report on Form 20-F and furnishes current information on Form 6-K. Its Form F-1 registration statement for Class A ordinary shares was declared effective by the U.S. Securities and Exchange Commission in connection with the company’s initial public offering. Subsequent Form 6-K reports have included unaudited interim consolidated financial statements and an operating and financial review for a six-month period, giving investors insight into Pitanium’s interim results and financial condition.
Pitanium’s Form 6-K filings also document important regulatory and trading events. The company reported that the SEC issued an order suspending trading in its securities for a specified period and that Nasdaq later announced a trading halt pending additional information. In these filings, Pitanium described its responses to information requests from Nasdaq, its intention to cooperate with the SEC, Nasdaq, and other regulatory authorities, and its statements that the Group’s business operations remained normal without material change to its operations or financial position as of the report dates.
On this page, users can review PTNM’s SEC filings as they are made available, including registration materials, interim financial reports, and current reports describing trading suspensions, trading halts, and related regulatory communications. AI-powered tools can help summarize lengthy documents, highlight key disclosures, and make complex filing language easier to understand for those analyzing Pitanium’s regulatory history and reporting as a Nasdaq-listed foreign private issuer.
Pitanium Ltd (PTNM) said Nasdaq delisted its Class A ordinary shares effective October 11, 2026. Nasdaq filed Form 25 on October 1, 2026; withdrawal of the shares’ Section 12(b) registration is expected 90 days after that filing, unless the SEC determines otherwise.
On September 28, 2026, the board approved a proposed Form 15 filing. Pitanium intends to file Form 15, subject to applicable eligibility requirements, to terminate any applicable Section 12(g) registration and suspend Section 15(d) reporting obligations. Upon filing, its remaining Exchange Act reporting obligations, including Form 20-F and Form 6-K reports, are expected to be suspended immediately if the requirements are met. Any Section 12(g) termination is expected to become effective 90 days after the Form 15 filing, unless the SEC determines otherwise.
After reporting obligations are suspended, Pitanium may no longer be required to provide periodic information to the SEC, which may reduce publicly available information. The delisting may adversely affect share liquidity; neither the delisting nor proposed Form 15 filing will by itself cancel outstanding Class A shares or alter their ownership rights.
Pitanium Ltd (PTNM) is the issuer named in Nasdaq Stock Market LLC’s Form 25 notification concerning removal from listing and/or registration of its Class A ordinary shares under Section 12(b) of the Exchange Act. Nasdaq certified that it had reasonable grounds to believe it met the Form 25 filing requirements.
Pitanium Limited, a Hong Kong-based skincare and personal care retailer, reports that it received a Nasdaq delisting determination letter dated July 7, 2026. The notice follows an October 3, 2025 SEC order suspending trading in the company’s securities, which cited potential manipulation concerns involving recommendations by unknown persons via social media.
Unless Pitanium requests an appeal by July 14, 2026, Nasdaq plans to suspend trading at the opening on July 16, 2026 and subsequently file Form 25-NSE to remove the securities from listing and registration. The company states that Nasdaq has not communicated any findings that Pitanium engaged in wrongdoing, that its operations and financial condition are unaffected, and that its securities may later be eligible for trading on the over-the-counter market, without assurance of an active trading market.
Pitanium Limited is introducing two new personal care product lines under its Pitanium brand while addressing the status of a trading halt in its securities. The Pi-ology Series uses biotechnological skincare and fermentation techniques to enhance ingredient activity, purity, stability, penetrability, and longevity, aiming to improve skin compatibility and deeper nutrient delivery. The Pi-Formance Series focuses on internal wellness, with targeted supplements such as women’s probiotics and hair follicle health formulas designed to strengthen the body from within and complement skincare benefits. The company states that these products will roll out gradually and emphasizes that product descriptions are not medical claims. Separately, Pitanium reports it has submitted responses and supporting materials to Nasdaq’s latest information requests and has responded to all comments and document requests from the SEC, Nasdaq, and FINRA. The company notes that business operations remain normal and uninterrupted as of the report date.
Pitanium Ltd director Cheng Wai Hei filed an initial ownership report on Form 3. This filing establishes Cheng Wai Hei’s status as a director and starting point for future insider ownership and trading disclosures. The filing does not list any transactions or derivative positions.
Pitanium Ltd director Lui Achilles Cheong Lung filed an initial ownership report on Form 3. The filing does not list any common stock or derivative holdings and shows no buys, sells, option exercises, gifts, or other transactions. This is a routine compliance filing establishing his insider reporting status.
Pitanium Ltd director Lee Kui Gee Jennifer filed an initial Form 3 reporting beneficial ownership. The filing shows no reportable transactions or holdings, with zero buys, sells, exercises, gifts, or other changes disclosed. This is a baseline disclosure of insider ownership status at the time of becoming a reporting person.
Pitanium Ltd filed an initial insider ownership report for its Chief Financial Officer, Mok Yau. This Form 3 filing lists no stock or derivative transactions and shows no reported holdings in the excerpt, serving mainly as a baseline disclosure of the CFO’s status as an officer.
Pitanium Ltd director and 10% owner Young Yuen Yi reported existing shareholdings in a Form 3. The filing shows direct ownership of 8,333,330 Class A Ordinary Shares and 1,500,000 Class B Ordinary Shares following the reported positions. This is an initial ownership report and does not reflect new buy or sell transactions.